Braskem S.A.
(BAK)
Price delayed 15 minutes
- Income Statement
- Blance Sheet
- Cash Flow Statement
Financial Statements
- Key Metrics
- Profitability
- Growth
- Valuation Multiples
- Operating Efficiency
- Liquidity & Solvency
- Cash
Ratio Analytics
My Watchlist
Log in to view your watchlist.
Growth Rates
| 2021 | 2020 | ||||
|---|---|---|---|---|---|
| 1-Year Growth: | |||||
| Revenue | 80.42% | 11.89% | |||
| Net Income | - | - | |||
| Operating Income | - | - | |||
| Total Assets | 7.53% | 26.35% | |||
| Stockholders Equity | - | -145.08% | |||
| Intangibles & Goodwill | 1.71% | 2.41% | |||
| Capex | - | - | |||
| Free Cash Flows (Unlevered) | 101.12% | 82.97% | |||
| Free Cash Flows (Levered) | - | - | |||
| R&D Expense | 18.49% | 1.18% | |||
| Dividends | 299,550% | -99.7% | |||
| Â | |||||
| 3-Year Growth: | |||||
| Revenue | 82.11% | 18.84% | |||
| Net Income | 387.85% | -271.82% | |||
| Operating Income | 213.63% | -102.44% | |||
| Total Assets | 56.37% | 61.38% | |||
| Stockholders Equity | 15.89% | -133.79% | |||
| Intangibles & Goodwill | 4.96% | 3.73% | |||
| Capex | - | - | |||
| Free Cash Flows (Unlevered) | 52.3% | 69.44% | |||
| Free Cash Flows (Levered) | -101.19% | - | |||
| R&D Expense | 48.63% | 50.09% | |||
| Dividends | 299.56% | -99.8% | |||
| Â | |||||
| 5-Year Growth: | |||||
| Revenue | 121.6% | 23.82% | |||
| Net Income | - | -323.4% | |||
| Operating Income | 337.62% | -103.24% | |||
| Total Assets | 78.62% | 43.57% | |||
| Stockholders Equity | 187.23% | -208.89% | |||
| Intangibles & Goodwill | 2.42% | -2.04% | |||
| Capex | - | - | |||
| Free Cash Flows (Unlevered) | 137.78% | -25.81% | |||
| Free Cash Flows (Levered) | -102.36% | -122.96% | |||
| R&D Expense | 83.32% | 42.07% | |||
| Dividends | 199.95% | -99.59% | |||